This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gough, S. C. L. Articles by O’Donovan, M. C. Search for Related Content PubMed PubMed Citation Articles by Gough, S. C. L. Articles by O’Donovan, M. C. Social Bookmarking                   What's this?

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

Institute of Biomedical Research, University of Birmingham, Birmingham, UK, s.c.gough{at}bham.ac.uk

Michael C. O’Donovan

Department of Psychological Medicine, Cardiff University, Cardiff, UK

People with schizophrenia are more likely to develop type 2 diabetes than the general population. Although an increased risk of diabetes has been attributed to environmental determinants such as diet, lifestyle and antipsychotic drugs, the association between these two disorders was noticed well before the advent of current lifestyles and pharmacological interventions, raising the possibility of a shared genetic basis. Schizophrenia and type 2 diabetes are common diseases with a complex mode of inheritance which includes both genetic factors and environmental determinants. As susceptibility genes for both type 2 diabetes and schizophrenia are beginning to be identified there is increasing interest in the possibility of shared susceptibility loci between the two conditions. This article reviews the genetic basis to schizophrenia and type 2 diabetes and discusses the potential for shared loci between both conditions.

Key Words: diabetes • schizophrenia • shared genes • genetics • clustering of diabetes and schizophrenia

Journal of Psychopharmacology, Vol. 19, No. 6 suppl, 47-55 (2005)
DOI: 10.1177/0269881105058380


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. J. Williams, M. J. Owen, and M. C. O'Donovan Schizophrenia genetics: new insights from new approaches Br. Med. Bull., May 14, 2009; (2009) ldp017v1. [Abstract] [Full Text] [PDF]

				B. D. Mitchell Editorial: Clustering of Schizophrenia With Other Comorbidities--What Can We Learn? Schizophr Bull, March 1, 2009; 35(2): 282 - 283. [Full Text] [PDF]

				S. Saha, D. Chant, and J. McGrath A Systematic Review of Mortality in Schizophrenia: Is the Differential Mortality Gap Worsening Over Time? Arch Gen Psychiatry, October 1, 2007; 64(10): 1123 - 1131. [Abstract] [Full Text] [PDF]

				H. Juvonen, A. Reunanen, J. Haukka, M. Muhonen, J. Suvisaari, R. Arajarvi, T. Partonen, and J. Lonnqvist Incidence of Schizophrenia in a Nationwide Cohort of Patients With Type 1 Diabetes Mellitus Arch Gen Psychiatry, August 1, 2007; 64(8): 894 - 899. [Abstract] [Full Text] [PDF]

				A.H. Barnett, P. Mackin, I. Chaudhry, A. Farooqi, R. Gadsby, A. Heald, J. Hill, H. Millar, R. Peveler, A. Rees, et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia J Psychopharmacol, June 1, 2007; 21(4): 357 - 373. [Abstract] [PDF]